A closer look at how local protein production is altered in ALS

The functioning of neurons, cells that transmit information in the nervous system, heavily relies on the production of ...
FiercePharma

ALS med Radicava to change hands as Shionogi inks $2.5B buyout

Pharma's end-of-year dealmaking flurry is not showing signs of slowing, as, now, two Japanese drugmakers have joined the action with a multibillion-dollar asset transfer agreement. Monday, Shionogi ...
ALZFORUM

Research Models

Dozens of rodents have been generated that model various aspects of ALS, like motor impairment or degeneration of motor neurons. No model recapitulates the human disease perfectly. By organizing ...
Hosted on MSN

New ALS drug stabilizes decline with a trend toward improved strength and mobility for some

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, ...
ALS News Today

COYA 302 trial in ALS expands to Canada after regulatory nod

Health Canada has given its okay to an ongoing trial testing COYA 302 for ALS, expanding the ALSTARS study to Canada. COYA 302 aims to slow ALS progression by reducing inflammation and boosting ...
IEEE

Large-Scale ALS Point Cloud Segmentation via Projection-Based Context Embedding

Abstract: Semantic segmentation of airborne laser scanning (ALS) point clouds is a valuable yet challenging task in remote sensing. When processing large-scale ALS scenes, it is necessary to partition ...